ArticleBioscience reports2022

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.

Yin-Qiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.